Reaktion #1519902

ord-3a4b3232dcca4ca49d47e16805a7035f

Reaktionsgleichung

CCC(CC)c1cc(C)nn2cc(C)nc12
8-(1-ethyl-propyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine
Cc1noc(C)c1Br
4-bromo-3,5-dimethyl isoxazole
O=C([O-])[O-].[Cs+].[Cs+]
cesium carbonate
CCC(CC)c1cc(C)nn2c(-c3c(C)noc3C)c(C)nc12
title compound
Ausbeute 23.1%
CCC(CC)c1cc(C)nn2c(-c3c(C)noc3C)c(C)nc12
3-(3,5-dimethyl isoxazol-4-yl)-8-(1-ethyl-propyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine
Ausbeute 23.1%

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Vorschrift

Using the procedure analogous to Example 242, from 8-(1-ethyl-propyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine (200 mg, 0.90 mmol), 4-bromo-3,5-dimethyl isoxazole (Alfa, 320 mg, 1.8 mmol), cesium carbonate (880 mg, 2.70 mmol) and PdCl2(PPh3)2 (25 mg) in DMF (5 ml), heated at 130 for 4 hrs, then overnight at ambient temperature gives the title compound (65 mg, 23% yield). ES-MS (m/z): calc'd for C18H24N4O: 312.4; found 313.2 (M+H)+. 1H NMR (400 mHz, CDCl3): δ 6.68 (s, 1H), 3.32 (m, 1H), 2.50 (s, 3H), 2.39 (s, 3H), 2.33 (s, 3H), 2.19 (s, 3H), 1.82 (m, 4H), 0.87 (m, 6H).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07612067B2uspto-grants-2009_11